Deep cerebral venous thrombosis (DCVT) remains a very rare entity among the spectrum
of cerebral venous thrombosis (CVT). Due to the bilateral draining territories, DCVT
typically results in bilateral thalamic infarction, with occasional extension into
the basal ganglia, with predictably dismal prognosis. Its most common clinical manifestations
are headache, seizures, changes in consciousness, and signs of nervous system lesions
during physical examination. This nonspecific clinical manifestation makes the diagnosis
of DCVT difficult.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Emergency MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Thrombosis of the cerebral veins and sinuses.N Engl J Med. 2005; 352: 1791-1798
- Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT).Stroke. 2004; 35: 664-670
- Thalamic lesions caused by deep cerebral venous thrombosis: a retrospective study.Eur Neurol. 2015; 74: 118-126
- Anticoagulation for cerebral venous sinus thrombosis.Cochrane Database Syst Rev. 2011; CD002005
- Heparin treatment in sinus venous thrombosis.Lancet. 1991; 338: 597-600
- Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.Stroke. 1999; 30: 484-488
Article info
Publication history
Published online: October 18, 2022
Accepted:
October 11,
2022
Received in revised form:
September 3,
2022
Received:
June 22,
2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
